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Abstract
Objective: To compare Bax protein expression in 
throphoblast cells of early and late onset PE.
Methods: A cross sectional study involving 36 cases of early 
onset PE and 36 cases of late onset PE was conducted. Bax 
protein expression was evaluated from sample of placental 
tissue collected from the study population and calculated 
using H-Score. Data on age, number of parity, gestational 
age, body mass index was collected from the medical 
records. Expression of Bax was compared using Mann-
Whitney test.
Result: There was no difference in the clinical characteristics 
(age, number of parity, BMI, SBP, DBP, and MAP) between the 
two groups. There was no difference in the expression of Bax 
protein between the early and late onset PE (mean H-score 
early vs. late onset PE: 1.48 vs 1.46, p=0.814, Mann Whitney 
U test). Clinical characteristics of the study population also 
did not correlate with the Bax expression (R for number of 
parity: 0.052, age: 0.009, gestational age: -0.014, BMI: 0.063, 
all p values were >0.05, linear regresion).
Conclusions: There is no difference in the expression of Bax 
protein of throphoblast cells between early and late onset 
PE.
Keywords: apoptosis, BAX, early onset, late onset, 
preeclampsia.
Abstrak
Tujuan: Untuk membandingkan ekspresi protein Baks dalam 
sel trofoblas pada preeklamsia (PE) onset dini dan lambat.
Metode: Sebuah studi potong lintang yang melibatkan 36 
kasus PE onset dini dan 36 kasus PE onset lambat dilakukan. 
Ekspresi protein Baks dievaluasi dari sampel jaringan 
plasenta yang dikumpulkan dari populasi studi dan dihitung 
menggunakan skor-H. Data usia, jumlah paritas, usia 
kehamilan, indeks massa tubuh dikumpulkan dari rekam 
medis. Ekspresi Baks dibandingkan menggunakan uji Mann-
Whitney.
Hasil: Tidak terdapat perbedaan pada karakteristik klinis 
(usia, jumlah paritas, IMT, TDS, TDD, dan MAP) antara kedua 
kelompok. Tidak terdapat perbedaan dalam ekspresi protein 
Bax antara PE onset dini dan lambat (rata-rata H-skor PE 
onset dini dan lambat: 1.48 vs 1.46, p = 0.814, uji Mann 
Whitney U). Karakteristik klinis populasi studi juga tidak 
berkorelasi dengan ekspresi Bax (R untuk jumlah paritas: 
0,052, usia: 0,009, usia kehamilan: -0,014, BMI: 0,063, nilai p 
dari semua variable tersebut adalah sebesar >0,05, dengan 
menggunakan regresi linier).
Kesimpulan: Tidak terdapat perbedaan dalam ekspresi 
protein Baks pada sel trofoblas antara PE onset dini dan 
lambat. 
Kata kunci: dapoptosis, baks onset dini, onset lambat, 
preeklamsia.
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Preeclampsia (PE) is a multisystem pathology 
of pregnancys characterized by the development 
of hypertension and its clinical consequences after 
20 weeks of gestational age. PE is still notorious 
for its high maternal and perinatal mortality. PE 
is a direct cause of maternal mortality worldwide 
which associated with severe complications (i.e. 
intracerebral bleeding, pulmonary edema, heart 
and renal failure). The worldwide incidence of 
PE varies between 3-5%. Annualy, there were 
approximately 500,000 maternal and 900,000 
perinatal deaths associated with PE in developing 
countries.1-3 The annual incidence of PE in 
Indonesia is even higher, i.e. between 5-10%. 
Most importantly, the rate tends to increase year 
to year. 
The exact mechanisms that underlie PE are still 
elusive. Hence, the treatment for PE is still mainly 
symptomatic. Several treatment modalities 
might reduce the risks for complication but the 
fi rm evidences assuring its safety for the mother 
and child are still lacking. Due to its elusive 
patho-mechanism, the effective prevention and 
treatment for PE is yet to be discovered. However, 
many experts believe that PE result from pathologic 
process that develops within the placenta. For 
example, the role of placental hypoxia that result 
from inadequate cytotrophoblasts invasion into 
the spiral arteries or inadequate spiral arterial 
remodeling that subsequently induce oxidative 
stress and endothelial dysfunction. The placenta 
in pregnancy with PE is suspected to be the source 
of oxidative stress and hence, the free radicals.4 
The apoptotic activity of the throphoblast may 
also play a crucial role in the development of PE, 
particularly the onset of development.
Therefore, this study is aimed to evaluate the 
expression of proapoptotic protein Bax within 
the throphoblast cells and compare it between 
early and late onset PE.
METHODS
This is a cross sectional study that involved 
singleton live pregnancy aged 20-40 weeks with 
early and late PE as case and control groups, 
respectively. The study was conducted at the 
Emergency Maternal Ward, Department of 
Obstetrics and Gynecology Dr. Sardjito General 
Hospital Yogyakarta from Mei 2020 to July 2020. 
The eligible subject who meet the inclusion 
criteria was recruited into the study population 
and a 3x3 cm placental tissue was sampled 
following delivery. Data were analyzed using 
SPSS for Windows version 24.
Bax protein expression was examined using 
immunohistochemistry. Bax protein expression 
was evaluated within the decidual thophoblast 
cells. HSCORE was calculated using the formula 
ƩPi x (i+1), in which Pi was the percentage of 
positive cells, i was the intensity of staining with 
value 0 for negative staining,  for weak staining, 
for moderate staining, and  for strong staining. 
H-Score was evaluated by three independent 
observers who were not aware about the identity 
and diagnosis of the sample. Inter-observer 
validation was done using intra-class correlation 
(r). Data on age, gestational age, parity and 
BMI were obtained from the medical records. 
Age, gestational age, number of parity, BMI 
and H-Score were analyzed for their normality 
using Shappiro-Wilk test. Mann-Whitney test 
was utilized to determine the difference of Bax 
protein expression between early and late PE. 
This study has been approved for ethical 
eligibility from the Research Ethics Committee 
of Medical Faculty of Universitas Gadjah Mada /
Dr. Sardjito General Hospital Yogyakarta Protocol 
Number KE/0703/07/2020.
RESULTS
Table 1 summarizes the characteristics of the 
study population. There was no difference in the 
age, number of parity, BMI, SBP, DBP, and MAP 
between the two groups.
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spiral arteries that begin in the fi rst trimester (16-
18 weeks). Late-onset PE is more common than 
the ealy-onset PE (2.7%-88% vs. 0.38% - 12%).5 
The infl uence of maternal age on the risk of 
PE is still controversial. In developed countries, 
advance maternal age (older than 35 years) 
has been associated with the increased risk of 
pregnancy complications such as abortion, fetal 
demise, gestational hypertension and PE). 
In this study, the clinical characteristics did 
not differ between the two groups. Similar result 
also reported, in which there were no difference 
of mean age between early and late PE (30.3 ± 
4.9  vs. 30.6 ± 6.9, p = 0.473).6 Early onset PE tend 
to occur in older age group, while late onset PE 
was associated with chronic hypertension.7 Low 
number of parity was associated with the earlier 
onset of PE, while multiparity was associated with 
the later onset of PE. Nulliparity has been cited 
as one the risk factors for the development of 
PE.8, The risk for PE in nulliparas was 1.1 (0.73-
1.66) but the association was not statistically 
signifi cant (p = 0.657).10 No signifi cant association 
between number of parity and the risk of PE.11 
Our study also reporting similar result in which 
no signifi cant difference in the number of parity 
between the two groups.
In this study, we demonstrate no difference in 
the expression of Bax protein between early and 
late onset PE. Similar result also demonstrated 
in which Bax expression did not differ between 
early and late onset PE. Immunohistochemistry 
offers signifi cant advantage for Bax protein 
characterization since it can refl ect the direct 
event of apoptosis in the placenta.12 It is practically 
and ethically diffi cult to evaluate Bax protein 
expression on the placenta to predict the future 
emergence of preeclampsia. However, results 
from this study provide important information 
and serve as a basic theory to further evaluate 
the association of Bax levels in the placenta and 
the development of PE.
Expression of Bax protein of throphoblast cells
Figure 1 represent Bax expression observed within 
the selected specimens. There was no difference 
in the expression of Bax protein between the early 
and late onset PE (Table 2). Clinical characterictis 
of the study population did not correlate with the 
Bax expression (Table 3).
Figure 1. Left. No staining or negative staining. Right. 
Variable staining depicting strong (red circle), moderate 
(yellow circle), and weak staining (green circle). 400x 
magnifi cation, light microscopy.
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Table 1.  Baseline Characteristics of the Study Population
Table 2. Comparison of Bax Expression between Early and 
Late Onset PE.
Table 3. Correlation between Baseline Characteristic and 
Bax Expression 
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Late onset PE
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DISCUSSION
PE can occur ealier in pregnancy (less than 
34 weeks) and hence, called early-onset PE, or 
later than 34 weeks of pregnancy. The difference 
in the onset may be attributed to the difference 
in invasive capacity of cytotrophoblasts into the 
CONCLUSION
We conclude that the expression of Bax protein 
in the throphoblast cells did not differ between 
early and late onset PE. We recommend further 
study that use more accurate evaluation of Bax 
expression such as radioimmunoassay of Western 
ligand blotting.
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